Biologic Therapies Improve Work Outcomes in Spondyloarthritis Save
A study from the British Society for Rheumatology Biologics Register in Axial Spondyloarthritis (BSRBR-AS) shows that biologic use significantly improves work productivity and overall activity impairment.
The BSRBR-AS registry analyzed 577 participants who were employed; 28% were started on biological therapy .
After 12-months of follow-up, those receiving biologic therapy had significantly greater improvements (relative to non-biological therapy) in presenteeism, overall work impairment, and overall activity impairment; however there was no difference in absenteeism.
There is consistent evidence that treatment with biological therapy improves these work and activity measures.
ADD THE FIRST COMMENT
Disclosures
The author has no conflicts of interest to disclose related to this subject
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.